Related Experiment Video

Updated: Dec 29, 2025

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
09:29

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice

Published on: July 14, 2023

1.1K

The signaling interplay of GSK-3β in myocardial disorders

Arun K Sharma1, Punniyakoti V Thanikachalam2, Saurabh Bhatia3

  • 1Department of Pharmacology, Amity Institute of Pharmacy, Amity University, Haryana 122413, India.

Drug Discovery Today
|February 5, 2020
PubMed

Insights

Glycogen synthase kinase-3 (GSK-3) plays a key role in heart conditions. Targeting GSK-3β shows therapeutic potential for improving heart health and survival.

Area of Science:

  • Biochemistry
  • Cardiology
  • Molecular Biology

Background:

  • Glycogen synthase kinase-3 (GSK-3) is a key regulator of cellular signaling pathways.
  • Dysregulation of GSK-3 is implicated in various pathological states, including heart failure.
  • GSK-3β, a specific isoform, is increasingly recognized for its role in myocardial homeostasis.

Purpose of the Study:

  • To review the multifaceted roles of GSK-3β in cardiac abnormalities.
  • To focus on recent findings regarding GSK-3β's impact on myocardial survival.
  • To discuss the therapeutic potential of GSK-3β inhibitors for cardioprotection.

Main Methods:

  • Literature review of recent investigations on GSK-3β in cardiac function.
  • Analysis of signaling pathways regulated by GSK-3β in the heart.
  • Evaluation of studies on GSK-3β inhibitors and their cardioprotective effects.

Main Results:

  • GSK-3β is involved in diverse cellular processes critical to cardiac health, including apoptosis and inflammation.
  • Targeting GSK-3β demonstrates potential for maintaining myocardial homeostasis and promoting survival.
  • Various GSK-3β inhibitors exhibit cardioprotective properties.

Conclusions:

  • GSK-3β is a significant factor in cardiac pathophysiology and a promising therapeutic target.
  • Understanding the complex roles of GSK-3β is crucial for developing novel treatments for heart disease.
  • Further research into GSK-3β inhibitors may lead to effective cardioprotective strategies.

More Related Videos

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity08:00

Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity

Published on: July 10, 2019

6.5K
Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

9.0K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
307
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.6K